Source link : https://newshealth.biz/health-news/novel-biologic-gets-narrow-win-for-preventing-copd-flare-ups/
(MedPage Today) — Novel anti-ST2 monoclonal antibody astegolimab modestly reduced chronic obstructive pulmonary disease (COPD) exacerbations in the phase IIb ALIENTO trial. The biologic dosed every 2 weeks reduced moderate or severe COPD exacerbations… Source link : https://www.medpagetoday.com/meetingcoverage/ers/117682 Author : Publish date : 2025-09-28 21:04:00 Copyright for syndicated content belongs to the linked Source.
The post Novel Biologic Gets Narrow Win for Preventing COPD Flare-ups first appeared on News Health.
—-
Author : News Health
Publish date : 2025-09-28 21:04:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8